Metastatic thyroid cancer occurring as an unknown primary lesion - The role of F-18FDG positron emission tomography

Dede F., Ajoedi N., Ansari S., Jana S., Heiba S., Abdel-Dayem H.

CLINICAL NUCLEAR MEDICINE, vol.26, no.5, pp.396-399, 2001 (SCI-Expanded, Scopus) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 26 Issue: 5
  • Publication Date: 2001
  • Doi Number: 10.1097/00003072-200105000-00004
  • Journal Name: CLINICAL NUCLEAR MEDICINE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.396-399
  • Keywords: F-18 fluorodeoxyglucose positron emission, tomography, metastatic thyroid cancer, unknown primary, PET
  • Marmara University Affiliated: No

Abstract

Thyroid cancer can appear as metastatic disease of an unknown primary origin, and fluorine-18 fluorodeoxyglucose (F-18 FDG) positron emission tomographic (PET) studies are helpful in the workup evaluation of these patients, The authors describe two patients who had metastatic disease from an unknown primary lesion, F-18 FDG PET studies played an important role in localizing the primary malignant site in the thyroid gland, The utility of F-18 FDG imaging in decreasing the number of procedures, cost, and inconvenience to patients is shown clearly in both cases.